In bladder cancer, tumor cells secreted CXCL2-stimulating nuclear factor kappa B (NF-κB) pathways in MDSCs to induce MDSC accumulation in the TME via CXCL2-CXCR2 signaling (Zhang et al., 2017). Here, CXCL2 is linked to urinary bladder cancer.